AzTrials
AzTrials

Post-extubation DysphagiaNCT06386159

Clinical Application of Comprehensive Intervention for PED Based on Neuroregulatory Mechanism

A study testing Comprehensive Intervention or Comprehensive Intervention Combined with Electrical vagus nerve stimulation in people with Post-extubation Dysphagia, run by Second Affiliated Hospital, Zhejiang University, School of Medicine at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study aims to establish a practical comprehensive intervention program for dysphagia after extubation in adult ICU patients based on the best evidence of its assessment and intervention, through expert panel discussion and Delphi method. Read more about this study

Who is it for?
Ages 18 to 90 years
Conditions the study is for
Post-extubation Dysphagia
What is being tested?
Comprehensive Intervention or Comprehensive Intervention Combined with Electrical vagus nerve stimulation
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
69 participants
Where
1 siteChina
Study dates
15 Mar 2024to 30 Jul 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients who met the diagnostic criteria of PED were changed to SSA score ≥24
  • aged from 18 to 90 years old;
  • oral or nasotracheal intubation for ≥48 hours;
  • Clear mind
  • Glasgow score ≥13 points, with good cooperation ability;
  • There was no contraindication to oral feeding after extubation

Who cannot join

  • Other diseases that affect swallowing function (such as stroke, Parkinson's disease, head and neck deformity, radiotherapy after head and neck cancer, burn with inhalation injury, esophageal cancer, chronic obstructive pulmonary disease, etc.);
  • history of reflux and aspiration;
  • tracheotomy;
  • isolation treatment due to respiratory infectious diseases;
  • the presence of implantable electronic devices (e.g., pacemakers, cochlear implants);
  • Traumatic vagus recurrent laryngeal nerve injury, history of vagus nerve surgery, or vagus nerve injury

Trial locations and contacts

1 site in 1 country.

China1 site, 1 recruiting
  • Jinhua Municipal Central Hospital

    Jinhua

    Haiping Xu, 13506587812, 240931013@qq.com

    Recruiting

Other trials in China

About this study

Official title: Clinical Application of Comprehensive Intervention Scheme for Post-extubation Dysphagia Based on Neuroregulatory Mechanism

This study aims to establish a practical comprehensive intervention program for dysphagia after extubation in adult ICU patients based on the best evidence of its assessment and intervention, through expert panel discussion and Delphi method. In addition, combining the preliminary experimental results of vagus nerve stimulation applied to PED patients, we further develop a comprehensive intervention program for dysphagia after extubation based on neural regulation mechanism. Finally, the implementation effect of this PED comprehensive intervention program based on neural regulation mechanism will be verified through clinical application.

Being tested
Comprehensive Intervention or Comprehensive Intervention Combined with Electrical vagus nerve stimulation
Keywords
post-extubation dysphagia, electrical stimulation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Comprehensive Intervention or Comprehensive Intervention Combined with Electrical vagus nerve stimulationOther

    Comprehensive intervention includes multidisciplinary collaboration, screening and assessment, oral sensory training, oral motor training, respiratory training, and feeding management. Transcutaneous electrical stimulation of the vagus nerve at the lateral neck was performed by rehabilitation therapists. The cervical vagus nerve accompanies the carotid artery and is located at the groove between the trachea and the sternocleidomastoid muscle, which can be located by touching the carotid pulse. The two electrodes were pasted along the path of the cervical vagus nerve.

Study groups in NCT06386159
Study groupRoleWhat they receive
Control GroupNo interventionDuring routine medical care and nursing, the responsible nurse provides daily oral care and delivers health education to patients and their caregivers regarding diet and swallowing safety. Within 8 hours after the removal of the endotracheal tube, the Standardized Swallowing Assessment (SSA) is used to screen for swallowing function. Patients are guided in food selection based on the severity of their swallowing difficulties and personal preferences, and are supplemented with enteral or parenteral nutrition or prescribed specific diets as directed by their doctor.
Comprehensive Intervention GroupActive comparatorOn the basis of the control group, a comprehensive intervention plan determined through Delphi expert consultation is implemented for PED patients. This plan includes multidisciplinary collaboration, screening and assessment, oral sensory training, oral motor training, respiratory training, and feeding management. The duration and frequency of the exercises are tailored to the patient's actual condition.
Receives: Other: Comprehensive Intervention or Comprehensive Intervention Combined with Electrical vagus nerve stimulation
Comprehensive Intervention Combined with Vagus Nerve Stimulation GroupExperimentalOn the basis of the control group, a comprehensive intervention is implemented in combination with vagus nerve electrical stimulation.
Receives: Other: Comprehensive Intervention or Comprehensive Intervention Combined with Electrical vagus nerve stimulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. functional oral intake scale(FOIS)

    FOIS consists of seven levels: ① Score 1, unable to eat orally at all; ② Score 2, dependent on tube feeding, minimum attempt to eat food or liquid; ③ Score 3, dependent on tube feeding, taking single texture food or liquid orally; ④ Score 4, completely oral intake of single texture food; ⑤ score 5: fully oral intake of a variety of food textures, but with special preparation or compensation; ⑥6 points, completely oral feeding without special preparation, but with special food restriction; ⑦7 points, complete oral feeding without restriction, the higher the score, the better the swallowing function of the patient. In this study, a FOIS score of 6-7 was defined as full oral feeding

    Measured: up to 90 days

  2. standardized Swallowing Assessment(SSA)

    The first part is the clinical examination.The second part involves observing the patient's ability to swallow 5 mL of water, repeated three times. If there are no abnormalities detected in the above examinations, the amount of water for swallowing is then increased to 60 mL. To obtain the total score, the scores from all three parts are summed up.

    Measured: up to 90 days

Secondary outcomes (12)
  1. Rate of total oral feeding after the intervention

    After the intervention, the patient's score on the Functional Oral Intake Scale (FOIS) was between 6 and 7, indicating that the patient has recovered the ability to eat orally.

    Measured: up to 90 days

  2. Duration of Enteral Nutrition Tube Indwelling

    The duration of the nasogastric tube or nasointestinal tube indwelling in the patient

    Measured: up to 90 days

  3. Rate of Re-intubation after Endotracheal Intubation

    The rate of re-intubation during the intervention period after extubation in patients who have undergone endotracheal intubation

    Measured: up to 90 days

  4. Incidence of aspiration within one week after extubation

    Incidence of aspiration within one week after extubation

    Measured: up to 90 days

  5. The incidence of aspiration pneumonia within one week after extubation

    The incidence of aspiration pneumonia within one week after extubation

    Measured: up to 90 days

  6. Inflammation-related indicators: serum C-reactive protein (CRP)

    Monitoring of patients' inflammatory marker

    Measured: up to 90 days

  7. Inflammation-related indicators: serum interleukin-6 (IL-6)

    Monitoring of patients' inflammatory marker

    Measured: up to 90 days

  8. Inflammation-related indicators: serum procalcitonin, acetylcholine (ACh)

    Monitoring of patients' inflammatory markers

    Measured: up to 90 days

  9. Inflammation-related indicators: high mobility group box-1 protein (HMGB1)

    Monitoring of patients' inflammatory marker

    Measured: up to 90 days

  10. Days of ICU hospitalization

    Days of ICU hospitalization

    Measured: up to 90 days

  11. Total days of hospitalization

    Total days of hospitalization

    Measured: up to 90 days

  12. In-hospital survival rate

    The number of patients who survive during hospitalization

    Measured: up to 90 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Apr 2024
  2. Study start15 Mar 2024
  3. Primary completion30 Apr 2025 (estimated)
  4. Study completion30 Jul 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
69 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06386159
Sponsor's protocol ID
2023-1178
Status last verified
Mar 2024
First submitted
24 Apr 2024
Last updated
1 Jul 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Comprehensive Intervention or Comprehensive Intervention Combined with Electrical vagus nerve stimulation in people with Post-extubation Dysphagia, run by Second Affiliated Hospital, Zhejiang University, School of Medicine at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 1 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Xiuqin Feng (13757119151, fengxiuqin@zju.edu.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

functional oral intake scale(FOIS) (time frame: up to 90 days). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jul 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in